Printer Friendly

A Decrease in the Number of Children Being Born has Impacted Sales in the Contraceptives Market in the United States.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c40266) has announced the addition of Contraceptives in the United States to their offering.

With an increasing number of generic oral contraceptives on the market, sales of condoms and oral contraceptives declined 6.1% between 2000 and 2005 (after inflation). These generic oral contraceptives can sell for as much as 80% less than brand name products.

Consumer data show that while 15% of adults use condoms, this number could increase, considering that the U.S. has the highest rate of STDs of all industrial countries. The U.S. government and many not-for-profit organizations are spending millions of dollars to promote safe sexual health and the use of condoms. Should a condom manufacturer choose to dovetail an educational marketing campaign with the government and private sector promotions to increase awareness, directed at all sectors, sales increases could be the result.

New product development is the primary market strategy of pharmaceutical companies, in particular, development of products with added health benefits like acne prevention and pre-menopausal relief. Condom manufacturers also have new products and are developing marketing campaigns to catch the attention of younger and higher risk consumers.

Several other factors are impacting sales in the market, including a declining female population of prime childbearing years. However, some of those challenges are offset by other factors, such as the reduced number of children being born and the increased number of women delaying childbirth or deciding against having children altogether. For condom manufacturers, two hurdles are increasing awareness of STD prevention among consumers and successfully promoting an increased-sensitivity condom.

This report clearly identifies the principal external factors driving or curtailing growth. Exclusive consumer research reveals the attitudes, needs and behavior of consumers, with analysis broken down both by demographic characteristics, and by segment.

Six years of specific sales data provide a factual and impartial presentation of the market as a whole. The report also evaluates the performance of individual sectors in the market, and provides information about the major companies and brands. Using the SPSS forecasting package, a five-year forecast of U.S. retail sales is created, revealing potential opportunities for growth and product development.

The contraceptive market is defined as including all products used for birth control or as prophylactics in sexual relationships. Included are non-permanent forms of contraception: oral contraceptives, chemical, barrier and hormone-releasing implant methods, whether available over-the-counter or on prescription. This includes male and female condoms, spermicides, diaphragms/caps, oral contraceptives (birth control pills), intra-uterine devices, and injections. Natural methods of birth control or permanent contraceptives such as tubaligation and vasectomy procedures are referred to in order to indicate trends within the market, but are not included in the market size.

Companies Mentioned

--Johnson & Johnson

--Barr Laboratories

--Condoms

--Church & Dwight

--Durex

--Ansell

For more information visit http://www.researchandmarkets.com/reports/c40266
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 3, 2006
Words:473
Previous Article:Over A Five Year Period the Cat Care Market Grew at an Annual Rate of 3.3% in the USA.
Next Article:Research and Markets: Pfizer Inc was the Leading Company Operating in the Pet Health Care Market in the USA.
Topics:


Related Articles
Pill cleared of breast cancer role.
Contraceptive consumers: gender and the political economy of birth control in the 1930s.
Simultaneous antibiotic, pill use reviewed. (News Briefs).
Contraceptive method switching in the United States.
Condom donations are shrinking. (FYI).
Protecting against unintended pregnancy: an overview of standard contraceptives.
Some women with genetic susceptibility to breast cancer face elevated risk from oral contraceptive use. (Digests).
Many parents of teenagers think parental involvement laws will increase risks.
Social, demographic and situational characteristics associated with inconsistent use of oral contraceptives: evidence from France.
In France, over-the-counter emergency contraception increases access, not risk.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters